A Phase IIb trial of A-101 45% Topical Solution in patients with common warts.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Adverse reactions
- Sponsors Aclaris Therapeutics
- 29 Jun 2017 Status changed from planning to recruiting, according to an Aclaris Therapeutics media release.
- 20 Mar 2017 New trial record
- 15 Mar 2017 According to an Aclaris Therapeutics media release, company is planning to initiate this trial in mid-2017.